Novartis recently signed a new contract with Hanmi Pharmaceutical as their co-sales contract with Handok ends
On July 9, according to the related industry, Novartis recently signed a new contract with Hanmi Pharmaceutical as their co-sales contract of 'Galvus (vildagliptin)' and metformin complex 'Galvusmet' with Handok ends.
Galvus and Januvia vied for first place. However, after the release of Trajent...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
